203 related articles for article (PubMed ID: 17936723)
1. Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels.
Bijman MN; Hermelink CA; van Berkel MP; Laan AC; Janmaat ML; Peters GJ; Boven E
Biochem Pharmacol; 2008 Jan; 75(2):427-37. PubMed ID: 17936723
[TBL] [Abstract][Full Text] [Related]
2. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
[TBL] [Abstract][Full Text] [Related]
3. [Celecoxib increased cellular ATRA sensitivity of human colon cancer cell lines through COX-2-independent mechanisms].
Liu JP; Wei HB; Zheng ZH; Guo WP; Fang JF
Yao Xue Xue Bao; 2009 Dec; 44(12):1353-8. PubMed ID: 21351468
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.
Kim SH; Kim SH; Song YC; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():635-41. PubMed ID: 19723114
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53.
Swamy MV; Herzog CR; Rao CV
Cancer Res; 2003 Sep; 63(17):5239-42. PubMed ID: 14500353
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
Liu B; Shi ZL; Feng J; Tao HM
Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic effect of celecoxib dependent upon p53 status in human ovarian cancer cells.
Song YC; Kim SH; Juhnn YS; Song YS
Ann N Y Acad Sci; 2007 Jan; 1095():26-34. PubMed ID: 17404014
[TBL] [Abstract][Full Text] [Related]
9. Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells.
El-Awady RA; Saleh EM; Ezz M; Elsayed AM
Toxicol Appl Pharmacol; 2011 Sep; 255(3):271-86. PubMed ID: 21763710
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
Maier TJ; Schilling K; Schmidt R; Geisslinger G; Grösch S
Biochem Pharmacol; 2004 Apr; 67(8):1469-78. PubMed ID: 15041464
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib antagonizes the cytotoxic effect of cisplatin in human gastric cancer cells by decreasing intracellular cisplatin accumulation.
Chen M; Yu L; Gu C; Zhong D; Wu S; Liu S
Cancer Lett; 2013 Feb; 329(2):189-96. PubMed ID: 23142285
[TBL] [Abstract][Full Text] [Related]
15. AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells.
Venkatesan P; Bhutia SK; Singh AK; Das SK; Dash R; Chaudhury K; Sarkar D; Fisher PB; Mandal M
Life Sci; 2012 Oct; 91(15-16):789-99. PubMed ID: 22922496
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative effect of a novel nitro-oxy derivative of celecoxib in human colon cancer cells: role of COX-2 and nitric oxide.
Bocca C; Bozzo F; Bassignana A; Miglietta A
Anticancer Res; 2010 Jul; 30(7):2659-66. PubMed ID: 20682995
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells.
Bocca C; Bozzo F; Cannito S; Parola M; Miglietta A
Mol Carcinog; 2012 Oct; 51(10):783-95. PubMed ID: 21882253
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib antagonizes the cytotoxicity of cisplatin in human esophageal squamous cell carcinoma cells by reducing intracellular cisplatin accumulation.
Yu L; Chen M; Li Z; Wen J; Fu J; Guo D; Jiang Y; Wu S; Cho CH; Liu S
Mol Pharmacol; 2011 Mar; 79(3):608-17. PubMed ID: 21177414
[TBL] [Abstract][Full Text] [Related]
20. The effects of combining docetaxel and cyclooxygenase-2 inhibitors on proliferation and apoptosis in epithelial ovarian cancer.
Munkarah AR; Ali-Fehmi R; Jiang JZ; Elhammady E; Malone JM; Saed GM
Anticancer Drugs; 2007 Sep; 18(8):889-96. PubMed ID: 17667594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]